Management of a sporadic malignant subfrontal peripheral nerve sheath tumor

Rene O Sanchez-Mejia1, Diep N Pham, Michael Prados

  • 1Department of Neurological Surgery, University of California, M-779, Box 0112, San Francisco, CA 94143, USA. sanchezr@neurosurg.ucsf.edu

Journal of Neuro-Oncology
|September 1, 2005
PubMed

Insights

Malignant subfrontal peripheral nerve sheath tumors (MPNSTs) are rare but can mimic meningiomas. Aggressive management is crucial for long-term control of these unusual, potentially malignant lesions.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Pathology

Background:

  • Subfrontal (olfactory) peripheral nerve sheath tumors (MPNSTs) are exceptionally rare.
  • Meningiomas are the most common subfrontal extra-axial lesions, often sharing radiographic similarities with MPNSTs.
  • Distinguishing between MPNSTs and meningiomas is critical due to differing management strategies.

Observation:

  • A 49-year-old woman presented with chronic sinusitis, headaches, and anosmia.
  • Imaging revealed a large left subfrontal mass extending into the sinuses and nasal cavity.
  • The patient had a subfrontal MPNST with unique histological features.

Findings:

  • The patient underwent a combined bifrontal transbasal craniotomy and transnasal approach for tumor resection.
  • Postoperative radiation therapy was administered.
  • One-year follow-up showed no evidence of tumor recurrence.

Implications:

  • Subfrontal MPNSTs, though rare, can manifest as a malignant variant requiring aggressive treatment.
  • This case highlights the importance of considering MPNSTs in the differential diagnosis of subfrontal masses.
  • Optimal surgical and adjuvant therapy are essential for achieving long-term tumor control in these rare malignancies.

Related Concept Videos